The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder
Abstract
BACKGROUND: Previous studies have demonstrated the short-term efficacy of pharmacotherapy and behavior therapy for attention-deficit/hyperactivity disorder (ADHD), but no longer-term (i.e., >4 months) investigations have compared these 2 treatments or their combination. METHODS: A group of 579 children with ADHD Combined Type, aged 7 to 9.9 years, were assigned to 14 months of medication management (titration followed by monthly visits); intensive behavioral treatment (parent, school, and child components, with therapist involvement gradually reduced over time); the two combined; or standard community care (treatments by community providers). Outcomes were assessed in multiple domains before and during treatment and at treatment end point (with the combined treatment and medication management groups continuing medication at all assessment points). Data were analyzed through intent-to-treat random-effects regression procedures. RESULTS: All 4 groups showed sizable reductions in symptoms over time, with significant differences among them in degrees of change. For most ADHD symptoms, children in the combined treatment and medication management groups showed significantly greater improvement than those given intensive behavioral treatment and community care. Combined and medication management treatments did not differ significantly on any direct comparisons, but in several instances (oppositional/aggressive symptoms, internalizing symptoms, teacher-rated social skills, parent-child relations, and reading achievement) combined treatment proved superior to intensive behavioral treatment and/or community care while medication management did not. Study medication strategies were superior to community care treatments, despite the fact that two thirds of community-treated subjects received medication during the study period. CONCLUSIONS: For ADHD symptoms, our carefully crafted medication management was superior to behavioral treatment and to routine community care that included medication. Our combined treatment did not yield significantly greater benefits than medication management for core ADHD symptoms, but may have provided modest advantages for non-ADHD symptom and positive functioning outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the MTA study, researchers found that although the combination of behavioral therapy and stimulant medication was not significantly more effective than treatment with medication alone for ADHD’s core symptoms, after correcting for multiple tests in the primary analysis,139”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [139]
In the citing paper
“Studies indicate that behavioral therapy has positive effects when it is combined with medication for preadolescent children.139”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [139]
In the citing paper
“Though debate persists over the neural mechanisms by which stimulants improve emotional lability, clinical experience has long suggested that stimulants can have positive, favorable effects on emotional lability.”
From Using Stimulants to Treat ADHD-Related Emotional Lability (2014) · cites this paper as [31]
In the citing paper
“Behavioral interventions, in contrast, are often more difficult to sustain over long durations, are generally more costly, and, arguably, may be less effective than stimulant medications—particularly for the core symptoms of ADHD”
From Improving Outcomes for Youth with ADHD: A Conceptual Framework for Combined Neurocognitive and Skill-Based Treatment Approaches (2014) · cites this paper as MTA Cooperative Group, 1999
In the citing paper
“Although evidence-based pharmacological and psychosocial treatments exist for ADHD, effects of these treatments are acute, do not typically generalize into non-treated settings, rarely sustain over time, and insufficiently affect key areas of functional impairment (i.e., family, social, and academic functioning) and executive functioning.”
From Improving Outcomes for Youth with ADHD: A Conceptual Framework for Combined Neurocognitive and Skill-Based Treatment Approaches (2014) · cites this paper as MTA Cooperative Group, 1999
In the citing paper
“these interventions do not normalize behavior for a significant number of youth with ADHD. As an example, Swanson and colleagues (2001) found that despite intensive, relatively long-term stimulant medication and behavioral treatment, one-third to two-thirds of youth with ADHD did not evince clinically significant improvements in the Multimodal Treatment of ADHD Study (MTA, 1999).”
From Improving Outcomes for Youth with ADHD: A Conceptual Framework for Combined Neurocognitive and Skill-Based Treatment Approaches (2014) · cites this paper as MTA, 1999
In the citing paper
“In the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA), medication use mediated the degree of baseline to 14-month, and 14-to 24-month changes in ADHD symptom ratings, buttressing the initial 14-month randomized clinical trial findings 4,5,15 that the use of a carefully monitored t.i.d.schedule of stimulant medication (with or”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [4]
In the citing paper
“579 children with ADHD combined type (aged 7Y9.9 years) were randomly assigned to medication management consisting of titration with t.i.d.administration of 5 to 20 mg of immediate-release MPH followed by monthly visits (MedMgt); behavior treatment consisting of intensive parent, school, and child components, with therapist involvement gradually reduced over time (Beh); the two combined (Comb); or”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [4]
In the citing paper
“Given the advantages of random-effects regression (RR) techniques over traditional analyses of variance for longitudinal clinical trials data, 4,11 we used RR for subsequent analyses”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [4]
In the citing paper
“subjects in the medication management and combination groups started with a 28-day, double-blind, daily-switch titration of MPH hydrochloride, using 5 randomly ordered repeats each of placebo, 5, 10, and 15 or 20 mg, with the higher dose, 15 mg versus 20 mg, being determined on the basis of the child's weight (threshold Q26 kg).”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [4]
In the citing paper
“There were no completed suicides.”
From European guidelines on managing adverse effects of medication for ADHD (2011) · cites this paper as [1]
In the citing paper
“In terms of severity and impact, most reports to the Multimodal Treatment Study of Children with ADHD (MTA) were of mild and transient symptoms that did not require hospitalisation [1].”
From European guidelines on managing adverse effects of medication for ADHD (2011) · cites this paper as [1]
Citations
Cites
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity
MARCH, J. S., PARKER, J. D. A., SULLIVAN, K., STALLINGS, P., & CONNERS, C. K. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00019 · Cited by 2,236
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738
Hinshaw, S. P. (1992) · Psychological Bulletin · doi:10.1037/0033-2909.111.1.127 · Cited by 1,689
DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.11.1673 · Cited by 935
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Helping the noncompliant child : a clinician's guide to parent training
Forehand, R., McMahon, R. J., & Wahler, R. G. (1981) · Guilford Press eBooks · Cited by 757
Empirically supported psychosocial treatments for attention deficit hyperactivity disorder
Pelham Jr, W. E., Wheeler, T., & Chronis, A. (1998) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2702_6 · Cited by 755
Some Conceptual and Statistical Issues in Analysis of Longitudinal Psychiatric Data
Gibbons, R. D. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210073009 · Cited by 719
Family-Environment Risk Factors for Attention-Deficit Hyperactivity Disorder
Biederman, J. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180050007 · Cited by 476
Increased Methylphenidate Usage for Attention Deficit Disorder in the 1990s
Safer, D. J., ZITO, J. M., & Fine, E. M. (1996) · PEDIATRICS · doi:10.1542/peds.98.6.1084 · Cited by 410
MIXOR: a computer program for mixed-effects ordinal regression analysis
Hedeker, D., & Gibbons, R. D. (1996) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(96)01720-8 · Cited by 408
Bryk, A. S., & Raudenbush, S. W. (1988) · American Journal of Education · doi:10.1086/443913 · Cited by 346
Gillberg, C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210105014 · Cited by 340
Defiant children : a clinician's manual for parent training
Barkley, R. A. (1987) · Guilford Press eBooks · Cited by 300
Richters, J., Arnold, L. E., Jensen, P., Abikoff, H., Conners, C., Greenhill, L. L., Hechtman, L., Hinshaw, S. P., Pelham, W., & Swanson, J. M. (1995) · Journal of the American Academy of Child and Adolescent Psychiatry · doi:10.1097/00004583-199508000-00008 · Cited by 299
Examination of DSM-IV Criteria for Attention Deficit/Hyperactivity Disorder in a County-Wide Sample
WOLRAICH, M. L., HANNAH, J. N., BAUMGAERTEL, A., & FEURER, I. D. (1998) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199806000-00003 · Cited by 292
Szatmári, P., OFFORD, D. R., & Boyle, M. H. (1989) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1989.tb00235.x · Cited by 290
Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., FEIL, M., & Burke, L. B. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00017 · Cited by 262
MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors
Hedeker, D., & Gibbons, R. D. (1996) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(96)01723-3 · Cited by 258
Hedeker, D., Gibbons, R. D., & Flay, B. R. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.4.757 · Cited by 254
Arnold, L. E. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210113015 · Cited by 240 · cited 1×
“01 4 73 (13) 17 (12) 18 (13) 15 (10) 23 (16) 7%-20%‡ 5 1 (0.”
Pharmacotherapy for Children with Attention-Deficit Hyperactivity Disorder
Pelham, W. E. (1993) · School Psychology Review · doi:10.1080/02796015.1993.12085647 · Cited by 207
Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.
Schachar, R., Tannock, R., Cunningham, C. H., & Corkum, P. (1997) · Journal of the American Academy of Child and Adolescent Psychiatry · doi:10.1097/00004583-199706000-00011 · Cited by 202
Wells, K. C., Pelham, W. E., Kotkin, R. A., Hoza, B., Abikoff, H., Abramowitz, A. J., Arnold, L. E., Cantwell, D. P., Conners, C. K., del Carmen, R., et al. (2000) · Research on Child and Adolescent Psychopathology · doi:10.1023/a:1005174913412 · Cited by 193
Hinshaw, S. P., Henker, B. A., Whalen, C. K., Erhardt, D., & Dunnington, R. E. (1989) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.57.5.636 · Cited by 167
Hinshaw, S. P., March, J. S., Abikoff, H., Arnold, L. E., Cantwell, D. P., Conners, C. K., Elliott, G. R., Halperin, J. M., Greenhill, L. L., Hechtman, L. T., et al. (1997) · Journal of Attention Disorders · doi:10.1177/108705479700100403 · Cited by 164
Behavior therapy and methylphenidate in the treatment of children with ADHD
KLEIN, R. G., & Abikoff, H. (1997) · Journal of Attention Disorders · doi:10.1177/108705479700200203 · Cited by 129
Ialongo, N. S., Horn, W. F., Pascoe, J. M., Greenberg, G. S., Packard, T. R., LOPEZ, M., WAGNER, A., & Puttler, L. I. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199301000-00026 · Cited by 116
Arnold, L. E., Abikoff, H., Cantwell, D. P., Conners, C. K., Elliott, G. R., Greenhill, L. L., Hechtman, L. T., Hinshaw, S. P., Hoza, B., Jensen, P. S., et al. (1997) · Journal of Attention Disorders · doi:10.1177/108705479700200301 · Cited by 84
Long, N. J., Rickert, V. I., & Ashcraft, E. W. (1993) · Journal of Pediatric Health Care · doi:10.1016/0891-5245(93)90078-v · Cited by 71
Kraemer, H. C. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90013-w · Cited by 63
Firestone, P., Crowe, D. J., Goodman, J. T., & McGrath, P. J. (1986) · American Journal of Orthopsychiatry · doi:10.1111/j.1939-0025.1986.tb02718.x · Cited by 57
Childhood attention deficit hyperactivity disorder: Nonpharmacological and combination treatments.
Hinshaw, S. P., KLEIN, R. G., & Abikoff, H. (1998) · Cited by 30
Assessing the services for children with ADHD: Gaps and opportunities
Sloan, M., Jensen, P. S., & KETTLE, L. (1999) · Journal of Attention Disorders · doi:10.1177/108705479900300102 · Cited by 29
Cited by
Sorted by citations
School readiness and later achievement.
Duncan, G. J., Dowsett, C. J., Claessens, A., Magnuson, K., Huston, A. C., Klebanov, P., Pagani, L. S., Feinstein, L., Engel, M., Brooks-Gunn, J., et al. (2007) · Developmental Psychology · doi:10.1037/0012-1649.43.6.1428 · Cited by 5,439
Mediators and Moderators of Treatment Effects in Randomized Clinical Trials
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.877 · Cited by 2,562
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Kraemer, H. C., Stice, E., Kazdin, A., Offord, D., & Kupfer, D. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.848 · Cited by 1,712
Metadata
- Authors
- The MTA Cooperative Group
- Corresponding author
- The MTA Cooperative Group
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1999-12-01
- Volume
- 56
- Issue
- 12
- Pages
- 1073
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2601578636
- Cited by
- 3,372
- References
- 35
- Citations by year
- 2026: 32 · 2025: 50 · 2024: 49 · 2023: 47 · 2022: 71 · 2021: 97 · 2020: 125 · 2019: 113 · 2018: 99 · 2017: 134 · 2016: 147 · 2015: 136 · 2014: 156 · 2013: 146 · 2012: 164
- FWCI
- 74.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institute of Mental Health (UO1 MH50461, UO1 MH50440, U01MH050447, U01MH050440, UO1 MH50447, U01MH050461)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- attention deficit hyperactivity disorder, combined type ADHD, medication management, community-based care, children, long-term treatment efficacy, parent training, school-based intervention, reading achievement, social skills, parent-child relationship, internalizing problems
- MeSH terms
- Central Nervous System Stimulants, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Child, Combined Modality Therapy, Community Mental Health Services, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Methylphenidate, Patient Acceptance of Health Care, Patient Compliance, Referral and Consultation, Regression Analysis, Comorbidity, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
